Cargando…
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
Background: Lipid polymer hybrid nanoparticles (LPHNPs) for the controlled delivery of hydrophilic doxorubicin hydrochloride (DOX.HCl) and lipophilic DOX base have been fabricated by the single step modified nanoprecipitation method. Materials and methods: Poly (D, L-lactide-co-glicolide) (PLGA), le...
Autores principales: | Tahir, Nayab, Madni, Asadullah, Correia, Alexandra, Rehman, Mubashar, Balasubramanian, Vimalkumar, Khan, Muhammad Muzamil, Santos, Hélder A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617603/ https://www.ncbi.nlm.nih.gov/pubmed/31308666 http://dx.doi.org/10.2147/IJN.S209325 |
Ejemplares similares
-
Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
por: Khan, Muhammad Muzamil, et al.
Publicado: (2019) -
Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
Publicado: (2020) -
Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
por: Khan, Muhammad Muzamil, et al.
Publicado: (2020) -
Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021) -
Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation
por: Mahmood, Muhammad Ahmad, et al.
Publicado: (2019)